776 related articles for article (PubMed ID: 6225514)
21. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
Miyachi H; Jiao L; Sowers LC; Scanlon KJ
In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
[TBL] [Abstract][Full Text] [Related]
22. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.
Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P
Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647
[TBL] [Abstract][Full Text] [Related]
23. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
24. Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.
Schultz RM; Chen VJ; Bewley JR; Roberts EF; Shih C; Dempsey JA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):68-73. PubMed ID: 10598558
[TBL] [Abstract][Full Text] [Related]
25. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells.
Yu M; Melera PW
Cancer Res; 1993 Dec; 53(24):6031-5. PubMed ID: 8261418
[TBL] [Abstract][Full Text] [Related]
26. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF
Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477
[TBL] [Abstract][Full Text] [Related]
27. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MH
Cancer Res; 1985 Mar; 45(3):978-82. PubMed ID: 3971388
[TBL] [Abstract][Full Text] [Related]
28. Resistance of human tumor cell lines to antifolates.
Diddens H; Niethammer D; Jackson RC
Cancer Treat Rev; 1984 Mar; 11 Suppl A():37-41. PubMed ID: 6234060
[No Abstract] [Full Text] [Related]
29. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
Mareya SM; Sorrentino BP; Blakley RL
Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
[TBL] [Abstract][Full Text] [Related]
30. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
[TBL] [Abstract][Full Text] [Related]
31. Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor.
O'Connor BM; Jackman AL; Crossley PH; Freemantle SE; Lunec J; Calvert AH
Cancer Res; 1992 Mar; 52(5):1137-43. PubMed ID: 1737372
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
[TBL] [Abstract][Full Text] [Related]
33. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
[TBL] [Abstract][Full Text] [Related]
34. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
[TBL] [Abstract][Full Text] [Related]
36. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
37. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
[TBL] [Abstract][Full Text] [Related]
38. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
Pizzorno G; Chang YM; McGuire JJ; Bertino JR
Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
[TBL] [Abstract][Full Text] [Related]
39. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
40. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
